Delivery Order SPE2DB20D2104-SPE2DB25FMCEK

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,761.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4568223554 - FLUOROURACIL 5% CREAM 40GM, with a period of performance extending through May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,732.34 firm fixed-price delivery order is for the supply of FLUOROURACIL 0.5% CREAM 30GM, with a performance period ending on December 3, 2021. The contract is not set aside for any specific business type, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluorouracil 0.5% cream in 30 gram quantities. The $2,352.07 firm fixed-price delivery order was made under a broader Indefinite Delivery Contract (IDC) with Cencora, Inc. (doing business as Amerisourcebergen) valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,274.86 firm fixed-price contract is for the delivery of 4555497530 - Fluorouracil 0.5% Cream 30GM, a pharmaceutical product. The contract has a completion date of November 23, 2021 and was awarded on November 22, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorouracil 5% cream. The contract has a ceiling value of $1,793.25 and a performance period extending through April 11, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.92 firm fixed-price delivery order is for the supply of Fluorouracil 5% topical solution, a medication used for the treatment of certain skin conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award, valued at $1,607.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of a medical product, "FLUORESCITE 10% VIAL 5ML", with a completion date of March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $1,676.21. The contract is for the supply of FLUORESCITE 10% VIAL 5ML, a medical product, to the Defense Logistics Agency, a defense agency. The contract is not set aside and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,349.86 delivery order contract is for the supply of 4564220384 - Sodium Fluoride 1.1% Cream, 51 grams. The contract has an ultimate completion date of April 10, 2024 and is a firm fixed price, delivery order type contract. The award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.93 firm fixed-price delivery order, which has an ultimate completion date of October 17, 2024, is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMCEK
    Delivery Order

This federal contract award, valued at $2,336.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of FLUOROURACIL 5% CREAM 40GM, a medical product used for various healthcare applications. The contract has an ultimate completion date of November 18, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/20/25, 2:20 PM